The global salivary gland infection treatment market is expected to garner a market value of USD 5054.79 Million in 2023 and is expected to accumulate a market value of USD 12,300 Million by registering a CAGR of 9.3% in the forecast period 2023 to 2033. Growth of the salivary gland infection treatment market can be attributed to growing prevalence of salivary gland infections along with availability of medications to treat the ailment.
The market for salivary gland infection treatment market registered a CAGR of 5% in the historical period 2018 to 2022
Salivary gland infection treatment refers to the medical care provided to individuals who have an infection in one or more of their salivary glands. The treatment approach depends on the severity and cause of the infection. In mild cases, treatment may include measures such as warm compresses, massage, and increased fluid intake to help alleviate symptoms and promote healing. In more severe cases, antibiotics may be prescribed to help clear the infection. If there is a blockage in the salivary gland, it may be necessary to perform a procedure to remove the obstruction. In rare cases, surgical intervention may be necessary to remove the affected gland.
| Report Attribute | Details |
|---|---|
| Expected Market Value (2023) | USD 5054.79 Million |
| Anticipated Forecast Value (2033) | USD 12,300 Million |
| Projected Growth Rate (2023 to 2033) | 9.3% CAGR |
According to market research and competitive intelligence provider Future Market Insights- the market for Salivary gland infection treatment reflected a value of 5% during the historical period, 2018 to 2022.
Research in the area of salivary gland infection treatment is ongoing, with a focus on developing more effective therapies and improving surgical techniques. Additionally, there is a growing interest in the use of alternative therapies, such as acupuncture and herbal medicine, for the management of salivary gland infections. Furthermore, key players in the market are focusing on innovating medication to offer various medications depending on the nature of the ailment.
Thus, the market for Salivary gland infection treatment is expected to register a CAGR of 9.3% in the forecast period 2023 to 2033.
Importance of oral hygiene driving salivary gland infection treatment market growth
The salivary gland infection treatment market is primarily driven by factors such as the increasing prevalence of salivary gland infections, the rising geriatric population, the growing awareness about the importance of oral hygiene, and the availability of various treatment options.
Other factors that are expected to contribute to market growth include advancements in diagnostic techniques, the increasing adoption of minimally invasive procedures, and the rising demand for personalized medicine. Additionally, the development of novel therapeutics and the increasing focus of key players on research and development activities are expected to create new opportunities for growth in the salivary gland infection treatment market.
Availability of treatments boosting market growth of salivary gland infection treatment
Antibiotics: If the infection is caused by bacteria, antibiotics are typically prescribed to treat the infection. The type of antibiotic used depends on the specific bacteria causing the infection. The course of antibiotics may last for several days to a few weeks, depending on the severity of the infection.
Pain relievers: Pain relievers such as acetaminophen or ibuprofen can help manage pain and inflammation associated with salivary gland infection.
Warm compresses: Applying a warm compress to the affected area can help reduce pain and swelling. The warmth helps to increase blood flow to the area and promote healing.
Sialagogues: These are medications that stimulate the production and flow of saliva. Sialagogues are sometimes prescribed to help clear blockages in the salivary gland duct and promote the flow of saliva, which can help flush out the infection.
Surgery: In severe cases, surgery may be required to drain an abscess or remove a stone that's blocking the salivary gland duct. Surgery may also be necessary if the infection is caused by a tumor.
Limited awareness and expensive treatment derailing growth of salivary gland infection treatment market
Salivary gland infections are often misdiagnosed or underdiagnosed due to their relatively uncommon nature and nonspecific symptoms. This can delay treatment and result in more serious complications. Antibiotics and other medications used to treat salivary gland infections can have side effects, which can impact patient compliance and satisfaction.
Limited awareness about salivary gland infections and their treatments, especially in developing countries, can limit access to appropriate care and delay treatment. While antibiotics are effective against bacterial infections, there are currently no specific antiviral drugs available to treat viral salivary gland infections.
The cost of treatment for salivary gland infections can be high, which may limit access to care for some patients. The overuse and misuse of antibiotics can contribute to the development of antibiotic-resistant bacteria, which can make treatment more difficult and less effective.
Increasing prevalence of infections propelling market growth in North America
The North America salivary gland infection treatment market is a significant segment of the global salivary gland infection treatment market. The region comprises of the USA, Canada, and Mexico. The market is driven by several factors such as the increasing prevalence of salivary gland infections, the availability of advanced healthcare infrastructure, and the presence of key players in the region.
The USA is the largest market in the region, owing to the high incidence of salivary gland infections and the growing awareness about oral hygiene. The increasing geriatric population and the rising demand for minimally invasive procedures are also contributing to market growth. Additionally, the presence of major pharmaceutical companies in the region, which are engaged in research and development activities to develop new and advanced treatment options, is expected to boost market growth.
Canada is also a significant market for salivary gland infection treatment, with increasing healthcare expenditure and rising awareness about oral hygiene. The presence of major medical device companies and the growing demand for minimally invasive procedures are also expected to contribute to market growth in the country.
Overall, the North America salivary gland infection treatment market is expected to experience steady growth over the coming years, driven by the increasing prevalence of salivary gland infections, the availability of advanced healthcare infrastructure, and the presence of key players in the region. Thus, North America is expected to possess 49% market share for salivary gland infection treatment market in 2023.
Advanced treatment options supporting growth of salivary gland infections treatment market in Europe
The Europe salivary gland infection treatment market is a significant segment of the global salivary gland infection treatment market. The region comprises of major countries such as Germany, France, the United Kingdom, Italy, Spain, and other European countries. The market is driven by several factors such as the high prevalence of salivary gland infections, increasing geriatric population, and rising awareness about oral hygiene.
Germany is the largest market in the region, owing to the increasing prevalence of salivary gland infections and the availability of advanced healthcare infrastructure. The country is also a leading manufacturer of medical devices, which is expected to contribute to the development of new and advanced treatment options.
The United Kingdom, France, Italy, and Spain are also significant markets for salivary gland infection treatment, driven by factors such as increasing healthcare expenditure, rising awareness about oral hygiene, and the growing geriatric population. Additionally, the presence of major pharmaceutical companies in the region is expected to boost market growth. Thus, Europe is expected to possess 43% market share for salivary gland infection treatment market in 2023.
Availability of painkillers and oral antibiotics making medication easy for salivary gland infection treatment
Antibiotics are often prescribed to treat bacterial salivary gland infections, as they can effectively kill the bacteria causing the infection. They are also widely available, and many patients can be treated with a simple course of oral antibiotics. In addition, over-the-counter painkillers such as acetaminophen or ibuprofen can be used to reduce pain and inflammation.
Medication can also help relieve other symptoms of salivary gland infections, such as fever, swelling, and difficulty swallowing. Salivary gland infections caused by viruses, such as mumps, do not have specific treatments. As a result, symptom relief and supportive care, such as rest and hydration, are the mainstay of treatment for viral salivary gland infections.
Medication is a non-invasive treatment option, which is particularly important for patients who may not be candidates for surgery or who wish to avoid surgical intervention. Thus, by treatment, medication is expected to possess 55% market share for gland infection treatment market in 2023.
Key players in the salivary gland infection treatment market are AbbVie Inc., Allergan, AstraZeneca, FUJIFILM Holdings Corporation, GlaxoSmithKline plc., Johnson & Johnson Services, Merck & Co., Inc., Pfizer Inc., Siemens Healthcare GmbH and Novartis AG
| Report Attribute | Details |
|---|---|
| Market Value in 2023 | USD 5054.79 Million |
| Market Value in 2033 | USD 12,300 Million |
| Growth Rate | CAGR of 9.3% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD Million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Diagnosis, Treatment, Distribution Channel, End User, Region |
| Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; MEA |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Rest of Latin America, Germany, United Kingdom, France, Spain, Italy, Rest of Europe, India, Malaysia, Singapore, Thailand, Rest of South Asia, China, Japan, South Korea, Austria, New Zealand, GCC countries, South Africa, Israel, Rest of MEA |
| Key Companies Profiled | AbbVie Inc.; Allergan; AstraZeneca; FUJIFILM Holdings Corporation; GlaxoSmithKline plc.; Johnson & Johnson Services; Merck & Co., Inc.; Pfizer Inc.; Siemens Healthcare GmbH; Novartis AG |
| Customization | Available Upon Request |
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Diagnosis, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Treatment, 2018 to 2033
Table 4: Global Market Value (US$ Million) Forecast by Distribution Channel , 2018 to 2033
Table 5: Global Market Value (US$ Million) Forecast by End-user, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 7: North America Market Value (US$ Million) Forecast by Diagnosis, 2018 to 2033
Table 8: North America Market Value (US$ Million) Forecast by Treatment, 2018 to 2033
Table 9: North America Market Value (US$ Million) Forecast by Distribution Channel , 2018 to 2033
Table 10: North America Market Value (US$ Million) Forecast by End-user, 2018 to 2033
Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 12: Latin America Market Value (US$ Million) Forecast by Diagnosis, 2018 to 2033
Table 13: Latin America Market Value (US$ Million) Forecast by Treatment, 2018 to 2033
Table 14: Latin America Market Value (US$ Million) Forecast by Distribution Channel , 2018 to 2033
Table 15: Latin America Market Value (US$ Million) Forecast by End-user, 2018 to 2033
Table 16: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 17: Europe Market Value (US$ Million) Forecast by Diagnosis, 2018 to 2033
Table 18: Europe Market Value (US$ Million) Forecast by Treatment, 2018 to 2033
Table 19: Europe Market Value (US$ Million) Forecast by Distribution Channel , 2018 to 2033
Table 20: Europe Market Value (US$ Million) Forecast by End-user, 2018 to 2033
Table 21: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 22: South Asia Market Value (US$ Million) Forecast by Diagnosis, 2018 to 2033
Table 23: South Asia Market Value (US$ Million) Forecast by Treatment, 2018 to 2033
Table 24: South Asia Market Value (US$ Million) Forecast by Distribution Channel , 2018 to 2033
Table 25: South Asia Market Value (US$ Million) Forecast by End-user, 2018 to 2033
Table 26: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 27: East Asia Market Value (US$ Million) Forecast by Diagnosis, 2018 to 2033
Table 28: East Asia Market Value (US$ Million) Forecast by Treatment, 2018 to 2033
Table 29: East Asia Market Value (US$ Million) Forecast by Distribution Channel , 2018 to 2033
Table 30: East Asia Market Value (US$ Million) Forecast by End-user, 2018 to 2033
Table 31: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 32: Oceania Market Value (US$ Million) Forecast by Diagnosis, 2018 to 2033
Table 33: Oceania Market Value (US$ Million) Forecast by Treatment, 2018 to 2033
Table 34: Oceania Market Value (US$ Million) Forecast by Distribution Channel , 2018 to 2033
Table 35: Oceania Market Value (US$ Million) Forecast by End-user, 2018 to 2033
Table 36: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 37: MEA Market Value (US$ Million) Forecast by Diagnosis, 2018 to 2033
Table 38: MEA Market Value (US$ Million) Forecast by Treatment, 2018 to 2033
Table 39: MEA Market Value (US$ Million) Forecast by Distribution Channel , 2018 to 2033
Table 40: MEA Market Value (US$ Million) Forecast by End-user, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Diagnosis, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Treatment, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Distribution Channel , 2023 to 2033
Figure 4: Global Market Value (US$ Million) by End-user, 2023 to 2033
Figure 5: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 6: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 9: Global Market Value (US$ Million) Analysis by Diagnosis, 2018 to 2033
Figure 10: Global Market Value Share (%) and BPS Analysis by Diagnosis, 2023 to 2033
Figure 11: Global Market Y-o-Y Growth (%) Projections by Diagnosis, 2023 to 2033
Figure 12: Global Market Value (US$ Million) Analysis by Treatment, 2018 to 2033
Figure 13: Global Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033
Figure 14: Global Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033
Figure 15: Global Market Value (US$ Million) Analysis by Distribution Channel , 2018 to 2033
Figure 16: Global Market Value Share (%) and BPS Analysis by Distribution Channel , 2023 to 2033
Figure 17: Global Market Y-o-Y Growth (%) Projections by Distribution Channel , 2023 to 2033
Figure 18: Global Market Value (US$ Million) Analysis by End-user, 2018 to 2033
Figure 19: Global Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033
Figure 20: Global Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033
Figure 21: Global Market Attractiveness by Diagnosis, 2023 to 2033
Figure 22: Global Market Attractiveness by Treatment, 2023 to 2033
Figure 23: Global Market Attractiveness by Distribution Channel , 2023 to 2033
Figure 24: Global Market Attractiveness by End-user, 2023 to 2033
Figure 25: Global Market Attractiveness by Region, 2023 to 2033
Figure 26: North America Market Value (US$ Million) by Diagnosis, 2023 to 2033
Figure 27: North America Market Value (US$ Million) by Treatment, 2023 to 2033
Figure 28: North America Market Value (US$ Million) by Distribution Channel , 2023 to 2033
Figure 29: North America Market Value (US$ Million) by End-user, 2023 to 2033
Figure 30: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 31: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 34: North America Market Value (US$ Million) Analysis by Diagnosis, 2018 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by Diagnosis, 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by Diagnosis, 2023 to 2033
Figure 37: North America Market Value (US$ Million) Analysis by Treatment, 2018 to 2033
Figure 38: North America Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033
Figure 39: North America Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033
Figure 40: North America Market Value (US$ Million) Analysis by Distribution Channel , 2018 to 2033
Figure 41: North America Market Value Share (%) and BPS Analysis by Distribution Channel , 2023 to 2033
Figure 42: North America Market Y-o-Y Growth (%) Projections by Distribution Channel , 2023 to 2033
Figure 43: North America Market Value (US$ Million) Analysis by End-user, 2018 to 2033
Figure 44: North America Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033
Figure 45: North America Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033
Figure 46: North America Market Attractiveness by Diagnosis, 2023 to 2033
Figure 47: North America Market Attractiveness by Treatment, 2023 to 2033
Figure 48: North America Market Attractiveness by Distribution Channel , 2023 to 2033
Figure 49: North America Market Attractiveness by End-user, 2023 to 2033
Figure 50: North America Market Attractiveness by Country, 2023 to 2033
Figure 51: Latin America Market Value (US$ Million) by Diagnosis, 2023 to 2033
Figure 52: Latin America Market Value (US$ Million) by Treatment, 2023 to 2033
Figure 53: Latin America Market Value (US$ Million) by Distribution Channel , 2023 to 2033
Figure 54: Latin America Market Value (US$ Million) by End-user, 2023 to 2033
Figure 55: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 59: Latin America Market Value (US$ Million) Analysis by Diagnosis, 2018 to 2033
Figure 60: Latin America Market Value Share (%) and BPS Analysis by Diagnosis, 2023 to 2033
Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Diagnosis, 2023 to 2033
Figure 62: Latin America Market Value (US$ Million) Analysis by Treatment, 2018 to 2033
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033
Figure 65: Latin America Market Value (US$ Million) Analysis by Distribution Channel , 2018 to 2033
Figure 66: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel , 2023 to 2033
Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel , 2023 to 2033
Figure 68: Latin America Market Value (US$ Million) Analysis by End-user, 2018 to 2033
Figure 69: Latin America Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033
Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033
Figure 71: Latin America Market Attractiveness by Diagnosis, 2023 to 2033
Figure 72: Latin America Market Attractiveness by Treatment, 2023 to 2033
Figure 73: Latin America Market Attractiveness by Distribution Channel , 2023 to 2033
Figure 74: Latin America Market Attractiveness by End-user, 2023 to 2033
Figure 75: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 76: Europe Market Value (US$ Million) by Diagnosis, 2023 to 2033
Figure 77: Europe Market Value (US$ Million) by Treatment, 2023 to 2033
Figure 78: Europe Market Value (US$ Million) by Distribution Channel , 2023 to 2033
Figure 79: Europe Market Value (US$ Million) by End-user, 2023 to 2033
Figure 80: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 84: Europe Market Value (US$ Million) Analysis by Diagnosis, 2018 to 2033
Figure 85: Europe Market Value Share (%) and BPS Analysis by Diagnosis, 2023 to 2033
Figure 86: Europe Market Y-o-Y Growth (%) Projections by Diagnosis, 2023 to 2033
Figure 87: Europe Market Value (US$ Million) Analysis by Treatment, 2018 to 2033
Figure 88: Europe Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033
Figure 89: Europe Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033
Figure 90: Europe Market Value (US$ Million) Analysis by Distribution Channel , 2018 to 2033
Figure 91: Europe Market Value Share (%) and BPS Analysis by Distribution Channel , 2023 to 2033
Figure 92: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel , 2023 to 2033
Figure 93: Europe Market Value (US$ Million) Analysis by End-user, 2018 to 2033
Figure 94: Europe Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033
Figure 95: Europe Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033
Figure 96: Europe Market Attractiveness by Diagnosis, 2023 to 2033
Figure 97: Europe Market Attractiveness by Treatment, 2023 to 2033
Figure 98: Europe Market Attractiveness by Distribution Channel , 2023 to 2033
Figure 99: Europe Market Attractiveness by End-user, 2023 to 2033
Figure 100: Europe Market Attractiveness by Country, 2023 to 2033
Figure 101: South Asia Market Value (US$ Million) by Diagnosis, 2023 to 2033
Figure 102: South Asia Market Value (US$ Million) by Treatment, 2023 to 2033
Figure 103: South Asia Market Value (US$ Million) by Distribution Channel , 2023 to 2033
Figure 104: South Asia Market Value (US$ Million) by End-user, 2023 to 2033
Figure 105: South Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 106: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 107: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 108: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 109: South Asia Market Value (US$ Million) Analysis by Diagnosis, 2018 to 2033
Figure 110: South Asia Market Value Share (%) and BPS Analysis by Diagnosis, 2023 to 2033
Figure 111: South Asia Market Y-o-Y Growth (%) Projections by Diagnosis, 2023 to 2033
Figure 112: South Asia Market Value (US$ Million) Analysis by Treatment, 2018 to 2033
Figure 113: South Asia Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033
Figure 114: South Asia Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033
Figure 115: South Asia Market Value (US$ Million) Analysis by Distribution Channel , 2018 to 2033
Figure 116: South Asia Market Value Share (%) and BPS Analysis by Distribution Channel , 2023 to 2033
Figure 117: South Asia Market Y-o-Y Growth (%) Projections by Distribution Channel , 2023 to 2033
Figure 118: South Asia Market Value (US$ Million) Analysis by End-user, 2018 to 2033
Figure 119: South Asia Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033
Figure 120: South Asia Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033
Figure 121: South Asia Market Attractiveness by Diagnosis, 2023 to 2033
Figure 122: South Asia Market Attractiveness by Treatment, 2023 to 2033
Figure 123: South Asia Market Attractiveness by Distribution Channel , 2023 to 2033
Figure 124: South Asia Market Attractiveness by End-user, 2023 to 2033
Figure 125: South Asia Market Attractiveness by Country, 2023 to 2033
Figure 126: East Asia Market Value (US$ Million) by Diagnosis, 2023 to 2033
Figure 127: East Asia Market Value (US$ Million) by Treatment, 2023 to 2033
Figure 128: East Asia Market Value (US$ Million) by Distribution Channel , 2023 to 2033
Figure 129: East Asia Market Value (US$ Million) by End-user, 2023 to 2033
Figure 130: East Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 131: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 132: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 134: East Asia Market Value (US$ Million) Analysis by Diagnosis, 2018 to 2033
Figure 135: East Asia Market Value Share (%) and BPS Analysis by Diagnosis, 2023 to 2033
Figure 136: East Asia Market Y-o-Y Growth (%) Projections by Diagnosis, 2023 to 2033
Figure 137: East Asia Market Value (US$ Million) Analysis by Treatment, 2018 to 2033
Figure 138: East Asia Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033
Figure 139: East Asia Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033
Figure 140: East Asia Market Value (US$ Million) Analysis by Distribution Channel , 2018 to 2033
Figure 141: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel , 2023 to 2033
Figure 142: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel , 2023 to 2033
Figure 143: East Asia Market Value (US$ Million) Analysis by End-user, 2018 to 2033
Figure 144: East Asia Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033
Figure 145: East Asia Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033
Figure 146: East Asia Market Attractiveness by Diagnosis, 2023 to 2033
Figure 147: East Asia Market Attractiveness by Treatment, 2023 to 2033
Figure 148: East Asia Market Attractiveness by Distribution Channel , 2023 to 2033
Figure 149: East Asia Market Attractiveness by End-user, 2023 to 2033
Figure 150: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 151: Oceania Market Value (US$ Million) by Diagnosis, 2023 to 2033
Figure 152: Oceania Market Value (US$ Million) by Treatment, 2023 to 2033
Figure 153: Oceania Market Value (US$ Million) by Distribution Channel , 2023 to 2033
Figure 154: Oceania Market Value (US$ Million) by End-user, 2023 to 2033
Figure 155: Oceania Market Value (US$ Million) by Country, 2023 to 2033
Figure 156: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 157: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 158: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 159: Oceania Market Value (US$ Million) Analysis by Diagnosis, 2018 to 2033
Figure 160: Oceania Market Value Share (%) and BPS Analysis by Diagnosis, 2023 to 2033
Figure 161: Oceania Market Y-o-Y Growth (%) Projections by Diagnosis, 2023 to 2033
Figure 162: Oceania Market Value (US$ Million) Analysis by Treatment, 2018 to 2033
Figure 163: Oceania Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033
Figure 164: Oceania Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033
Figure 165: Oceania Market Value (US$ Million) Analysis by Distribution Channel , 2018 to 2033
Figure 166: Oceania Market Value Share (%) and BPS Analysis by Distribution Channel , 2023 to 2033
Figure 167: Oceania Market Y-o-Y Growth (%) Projections by Distribution Channel , 2023 to 2033
Figure 168: Oceania Market Value (US$ Million) Analysis by End-user, 2018 to 2033
Figure 169: Oceania Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033
Figure 170: Oceania Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033
Figure 171: Oceania Market Attractiveness by Diagnosis, 2023 to 2033
Figure 172: Oceania Market Attractiveness by Treatment, 2023 to 2033
Figure 173: Oceania Market Attractiveness by Distribution Channel , 2023 to 2033
Figure 174: Oceania Market Attractiveness by End-user, 2023 to 2033
Figure 175: Oceania Market Attractiveness by Country, 2023 to 2033
Figure 176: MEA Market Value (US$ Million) by Diagnosis, 2023 to 2033
Figure 177: MEA Market Value (US$ Million) by Treatment, 2023 to 2033
Figure 178: MEA Market Value (US$ Million) by Distribution Channel , 2023 to 2033
Figure 179: MEA Market Value (US$ Million) by End-user, 2023 to 2033
Figure 180: MEA Market Value (US$ Million) by Country, 2023 to 2033
Figure 181: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 182: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 183: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 184: MEA Market Value (US$ Million) Analysis by Diagnosis, 2018 to 2033
Figure 185: MEA Market Value Share (%) and BPS Analysis by Diagnosis, 2023 to 2033
Figure 186: MEA Market Y-o-Y Growth (%) Projections by Diagnosis, 2023 to 2033
Figure 187: MEA Market Value (US$ Million) Analysis by Treatment, 2018 to 2033
Figure 188: MEA Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033
Figure 189: MEA Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033
Figure 190: MEA Market Value (US$ Million) Analysis by Distribution Channel , 2018 to 2033
Figure 191: MEA Market Value Share (%) and BPS Analysis by Distribution Channel , 2023 to 2033
Figure 192: MEA Market Y-o-Y Growth (%) Projections by Distribution Channel , 2023 to 2033
Figure 193: MEA Market Value (US$ Million) Analysis by End-user, 2018 to 2033
Figure 194: MEA Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033
Figure 195: MEA Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033
Figure 196: MEA Market Attractiveness by Diagnosis, 2023 to 2033
Figure 197: MEA Market Attractiveness by Treatment, 2023 to 2033
Figure 198: MEA Market Attractiveness by Distribution Channel , 2023 to 2033
Figure 199: MEA Market Attractiveness by End-user, 2023 to 2033
Figure 200: MEA Market Attractiveness by Country, 2023 to 2033
From 2018 to 2022, the Salivary gland infection treatment market grew at a CAGR of 5%
The global Salivary gland infection treatment market is expected to grow with a 9.3% CAGR during 2023 to 2033.
As of 2033, the Salivary gland infection treatment market is expected to reach USD 12,300 Million
Medication is expected to hold 55% of the market share in 2023 for Salivary gland infection treatment market.
North America is expected to possess 49% market share for Salivary gland infection treatment market in 2023.
Europe Salivary gland infection treatment market size is expected to possess 43% market share in 2023.
Explore Similar Insights
Salivary Gland Infection Treatment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
